Cartesian’s immune disorder therapy meets main goal in mid-stage study, ET HealthWorld
London:Cartesian Therapeutics said on Tuesday that its experimental therapy helped reduce symptoms of a rare, immune-related disorder, meeting the main goal in a mid-stage study. The therapy known as descartes-08…